Seagen (SGEN) Misses Q3 EPS by $1.04

Revenues

ADCETRIS net product sales

$700 million to $710 million

$675 million to $700 million

PADCEV net product sales

$330 million to $335 million

$310 million to $325 million

TUKYSA net product sales

$315 million to $325 million

$300 million to $315 million

Royalty revenues

$140 million to $150 million

$125 million to $135 million

Collaboration and license agreement revenues

$25 million to $30 million

Less than $20 million

Operating expenses and other costs

Cost of Sales

$295 million to $315 million

$270 million to $300 million

R&D expenses

$1,190 million to $1,240 million

$900 million to $1,000 million

SG&A expenses

$675 million to $725 million

$650 million to $725 million

$225 million to $245 million

Unchanged